Correction: Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis

Correction: Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117535/?tool=EBI

Similar Items

Immunomodulator clarithromycin enhances mucosal and systemic immune responses and reduces re-infection rate in pediatric patients with influenza treated with antiviral neuraminidase inhibitors: a retrospective analysis.
by: Wakako Shinahara, et al.
Published: (2013-01-01)

Correction: Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis.
Published: (2014-01-01)

NEURAMINIDASE INHIBITORS — THE GOLD STANDARD OF ANTIVIRAL INFLUENZA A THERAPY
by: V. V. TSVETKOV, et al.
Published: (2017-05-01)

Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus
by: Ohuchi Masanobu, et al.
Published: (2011-08-01)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
by: Tom Jefferson, et al.

Mechanisms of resistance to neuraminidase inhibitors in influenza A viruses and evaluation of combined antiviral therapy
by: Pizzorno, Mario Andres
Published: (2015)

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs
by: Meagan McMahon, et al.
Published: (2019-05-01)

Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
by: Toshiyuki Hikita, et al.
Published: (2012-01-01)

INTRAVENOUS CLARITHROMYCIN: A VALUABLE IMMUNOMODULATOR FOR SEVERE INFECTIONS
by: Leventogiannis Konstantinos, et al.
Published: (2014-04-01)

Intravenous clarithromycin: A valuable immunomodulator for severe infections
by: Leventogiannis Konstantinos, et al.
Published: (2014-01-01)

Influenza A viruses and their resistance to neuraminidase inhibitors
by: Baz Etchebarne, Mariana
Published: (2006)

Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01)

Systematic review of influenza resistance to the neuraminidase inhibitors
by: Boivin Guy, et al.
Published: (2011-05-01)

The Role of Neuraminidase Inhibitors in the Treatment and Prevention of Influenza
by: Naem Shahrour
Published: (2001-01-01)

Exploring the chemical space of influenza neuraminidase inhibitors
by: Nuttapat Anuwongcharoen, et al.
Published: (2016-04-01)

Influenza A viruses and their resistance to neuraminidase inhibitors
by: Baz Etchebarne, Mariana
Published: (2006)

Synthesis of Peramivir Analogues as Influenza Neuraminidase Inhibitors
by: Jo-Chi Yu, et al.
Published: (2015)

Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor.
by: Tomoko Nishikawa, et al.
Published: (2012-01-01)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
by: Doshi, Peter, et al.
Published: (2009)

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
by: Kamali A, et al.
Published: (2013-11-01)

The Battle against Influenza: The Role of Neuraminidase Inhibitors in Children
by: Upton Allen
Published: (2000-01-01)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
by: Vernon J. Lee, et al.
Published: (2006-01-01)

Treatment and prophylaxis of influenza and the problem of resistance to neuraminidase inhibitors
by: Aneta Nitsch- Osuch, et al.
Published: (2015-09-01)

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
by: E. R. Job, et al.
Published: (2019-10-01)

Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development
by: Nanyu Han, et al.
Published: (2020-08-01)

Antiviral Activity of Isoimperatorin Against Influenza A Virus in vitro and its Inhibition of Neuraminidase
by: Yanni Lai, et al.
Published: (2021-04-01)

Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.
by: Laura E Liao, et al.
Published: (2017-01-01)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
by: Yacine Abed, et al.
Published: (2019-04-01)

Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection.
by: Takuro Mizuno, et al.
Published: (2014-01-01)

Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity
by: Pedro Laborda, et al.
Published: (2016-11-01)

Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease
by: Alexander L. Pukhalsky, et al.
Published: (2004-01-01)

Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
by: Momoko Mawatari, et al.
Published: (2019-01-01)

Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.
by: Andreas Handel, et al.
Published: (2007-12-01)

Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
by: César Parra-Rojas, et al.
Published: (2018-08-01)

Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza
by: Wailoo, Alan J, et al.
Published: (2008)

Effectiveness of Neuraminidase Inhibitors for Preventing Staff Absenteeism during Pandemic Influenza
by: Vernon J. Lee, et al.
Published: (2007-03-01)

Synthesis of Anti-Influenza Neuraminidase Inhibitor Tamiphosphor by “One-Pot” Sequence
by: Yi-Wei Lo, et al.
Published: (2013)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
by: Nipaporn Tewawong, et al.
Published: (2018-01-01)

Studies on the Neuraminidase of Influenza Virus
by: Groome, N. P.
Published: (1975)

Antiviral and Immunomodulation Effects of Artemisia
by: Suhas G. Kshirsagar, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_0eni9qe1md60enucsh2rpqdclf